Loading…
Reported covered position: Chief of Staff, Representative Dave Camp
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Advocacy to expand research, access, and federal support for psychedelic-assisted therapies to address PTSD, depression, and other mental health conditions affecting veterans.
Advocacy to expand research, access, and federal support for psychedelic-assisted therapies to address PTSD, depression, and other mental health conditions affecting veterans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| APEXHEALTH |
| 16 |
| 2019–2022 |
| TOMPKINS STRATEGIES LLC (ON BEHALF OF AFFORDABLE HEALTHCARE FOR AMERICANS) | 16 | 2016–2020 |
| MERIDIAN HEALTH PLAN | 15 | 2015–2018 |
| VALYRIAN SMOKE LLC | 10 | 2021–2022 |
| CARECORE NATIONAL LLC | 9 | 2010–2012 |
| HEALING BREAKTHROUGH | 6 | 2023–2024 |
| VALOR COALITION | 5 | 2025–2026 |
| EVOLVE FOUNDATION INTERNATIONAL | 4 | 2023 |
| BUSINESS INTERRUPTION GROUP | 2 | 2020 |
| NORTHWEST POWER AND CONSERVATION COUNCIL | 1 | 2023 |
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
American Rescue Plan Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
American Rescue Plan Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
American Rescue Plan Act of 2021
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Lower Costs, More Cures Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Lower Costs, More Cures Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Lower Costs, More Cures Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Lower Costs, More Cures Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Lower Costs, More Cures Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage; and social determinants of health policy. S .Con. Res. 14 Budget Reconciliation.
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage; and social determinants of health policy. S .Con. Res. 14 Budget Reconciliation.
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Reduced Costs and Continued Cures Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Implementation of the Patient and Affordable Care Act (P.L. 11-148); Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Reduced Costs and Continued Cures Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Reduced Costs and Continued Cures Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Implementation of the Patient and Affordable Care Act (P.L. 11-148); Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
American Rescue Plan Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues.
American Rescue Plan Act of 2021
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148.
American Rescue Plan Act of 2021
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
American Rescue Plan Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
American Rescue Plan Act of 2021
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues.
American Rescue Plan Act of 2021
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · 3T
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, drug pricing, ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, drug pricing, ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · RR
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · 2A
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · 2T
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · 4A
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Serco contract and contracting opportunities with the Department of Health and Human Services.
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · 1A
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · RR
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · 3T
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · RR
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Defense
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Issues related to prescription drug coverage, supply chain, and pharmacy benefits.
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Defense
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · RR
expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
Federal Funding for NIH and NIMH research; expanding federal funding for Vets mental health research and treatments
Appropriations research funding, NIH, Veterans Affairs research funding
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Health and Human Services.
Serco contract and contracting opportunities with the Department of Defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation.
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co-Payments; Preferred Pharmacy Networks and Drug Rebates.
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2022 · fourth_quarter · Q4
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Health Benefits; State/Federal Health Exchanges; Health care Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; Medicare Advantage; Medicaid, Commercial Health Insurance; and COVID coverage issues.
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · 2A
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · 2A
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · 2A
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage; and social determinants of health policy. S .Con. Res. 14 Budget Reconciliation.
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
Federal Funding for NIH and NIMH research; expanding federal funding for Vets mental health research and treatments
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding
Appropriations research funding, NIH, Veterans Affairs research funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Defense
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2022 · third_quarter · Q3
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
Health Benefits; State/Federal Health Exchanges; Health care Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; Medicare Advantage; Medicaid, Commercial Health Insurance; and COVID coverage issues.
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Appropriations, Veterans Affairs
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder
Federal Funding for NIH and NIMH research; expanding federal funding for Vets mental health research and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2022 · second_quarter · Q2
Health Benefits; State/Federal Health Exchanges; Health care Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; Medicare Advantage; Medicaid, Commercial Health Insurance; and COVID coverage issues.
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
Appropriations, Veterans Affairs
Federal Funding for NIH and NIMH research; expanding federal funding for Vets mental health research and treatments
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Health and Human Services.
Serco contract and contracting opportunities with the Department of Defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
Implementation of the Patient and Affordable Care Act (P.L. 11-148); Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Preferred Pharmacy Networks and HHS Rebate Rule. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2022 · first_quarter · Q1
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage; and social determinants of health policy. S .Con. Res. 14 Budget Reconciliation.
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Defense
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
Implementation of the Patient and Affordable Care Act (P.L. 11-148); Legislation Amending or Repealing P.L. 111-148; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co- Payments; Essential Health Benefits; Preferred Pharmacy Networks and HHS Rebate Rule. HR 3684 Infrastructure Investment and Jobs Act. S. Con. Res. 14 Budget Reconciliation. HR 5260 Reduced Cost and Continued Care Act.
Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage and Direct Negotiation. S. Con. Res. 14 Budget Reconciliation.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.
HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2021 · fourth_quarter · Q4
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage; and social determinants of health policy. S .Con. Res. 14 Budget Reconciliation.
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing.
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
VALYRIAN SMOKE LLC via BLUESTONE STRATEGIES, LLC
2021 · third_quarter · Q3
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEXHEALTH via BLUESTONE STRATEGIES, LLC
2021 · third_quarter · Q3
Medicare Advantage (MA) Policy and Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Long-Term Care Insurance; Disability Insurance; Consumer Directed Health Products; Health Savings Accounts (HSAs); Flexible Savings Accounts (FSAs); COBRA and COVID Coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2166, Ensuring Parity in MA & PACE for Audio-Only Telehealth Act; Medicare Part D; Medicare Advantage (MA); Medigap; Medicaid; Dual Eligible Coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1319, The American Rescue Plan Act; Legislation Amending and Repealing P.L. 111-148; Essential Health Benefits; State/Federal Health Exchanges; Individual Mandate; Subsidies; Risk Corridors; Risk Adjustment; Cost Sharing Reduction; and COVID coverage issues. S.Con. Res. 14 Budget Reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE